[2]
Benjamin RJ, McLaughlin LS. Plasma components: properties, differences, and uses. Transfusion. 2012 May:52 Suppl 1():9S-19S. doi: 10.1111/j.1537-2995.2012.03622.x. Epub
[PubMed PMID: 22578375]
[3]
Peters T Jr. Intracellular precursor forms of plasma proteins: their functions and possible occurrence in plasma. Clinical chemistry. 1987 Aug:33(8):1317-25
[PubMed PMID: 3301066]
[6]
Loomans JI, Lock J, Peters M, Leebeek FW, Cnossen MH, Fijnvandraat K. [Haemophilia]. Nederlands tijdschrift voor geneeskunde. 2014:158():A7357
[PubMed PMID: 25351381]
[7]
Flood VH, Friedman KD, Gill JC, Morateck PA, Wren JS, Scott JP, Montgomery RR. Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function. Journal of thrombosis and haemostasis : JTH. 2009 Nov:7(11):1832-9. doi: 10.1111/j.1538-7836.2009.03594.x. Epub 2009 Aug 19
[PubMed PMID: 19694940]
[9]
Heim MU, Meyer B, Hellstern P. Recommendations for the use of therapeutic plasma. Current vascular pharmacology. 2009 Apr:7(2):110-9
[PubMed PMID: 19355994]
[10]
Garcia-Martinez R, Noiret L, Sen S, Mookerjee R, Jalan R. Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver international : official journal of the International Association for the Study of the Liver. 2015 Feb:35(2):335-43. doi: 10.1111/liv.12528. Epub 2014 Apr 1
[PubMed PMID: 24620819]
[11]
Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology (Baltimore, Md.). 2013 Nov:58(5):1836-46. doi: 10.1002/hep.26338. Epub 2013 May 14
[PubMed PMID: 23423799]
[12]
Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2013 Feb:11(2):123-30.e1. doi: 10.1016/j.cgh.2012.11.007. Epub 2012 Nov 22
[PubMed PMID: 23178229]
Level 1 (high-level) evidence
[13]
Traclet J, Delaval P, Terrioux P, Mornex JF. Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema. Revue des maladies respiratoires. 2015 Apr:32(4):435-46. doi: 10.1016/j.rmr.2014.10.001. Epub 2015 Apr 20
[PubMed PMID: 25908241]
[14]
Wewers MD, Crystal RG. Alpha-1 antitrypsin augmentation therapy. COPD. 2013 Mar:10 Suppl 1():64-7. doi: 10.3109/15412555.2013.764402. Epub
[PubMed PMID: 23527997]
[15]
Gosselin R, Hawes E, Moll S, Adcock D. Performance of various laboratory assays in the measurement of dabigatran in patients receiving therapeutic doses: a prospective study based on peak and trough plasma levels. American journal of clinical pathology. 2014 Feb:141(2):262-7. doi: 10.1309/AJCPRNUMI4PVSJ7Q. Epub
[PubMed PMID: 24436275]
[16]
McLeod BC. Plasma and plasma derivatives in therapeutic plasmapheresis. Transfusion. 2012 May:52 Suppl 1():38S-44S. doi: 10.1111/j.1537-2995.2012.03623.x. Epub
[PubMed PMID: 22578370]
[17]
Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. The Journal of the American Academy of Orthopaedic Surgeons. 2009 Oct:17(10):602-8
[PubMed PMID: 19794217]
[18]
Varacallo M, Chakravarty R, Denehy K, Star A. Joint perception and patient perceived satisfaction after total hip and knee arthroplasty in the American population. Journal of orthopaedics. 2018 Jun:15(2):495-499. doi: 10.1016/j.jor.2018.03.018. Epub 2018 Mar 30
[PubMed PMID: 29643693]
[19]
Varacallo MA, Herzog L, Toossi N, Johanson NA. Ten-Year Trends and Independent Risk Factors for Unplanned Readmission Following Elective Total Joint Arthroplasty at a Large Urban Academic Hospital. The Journal of arthroplasty. 2017 Jun:32(6):1739-1746. doi: 10.1016/j.arth.2016.12.035. Epub 2016 Dec 27
[PubMed PMID: 28153458]
[21]
Huang Y, Liu X, Xu X, Liu J. Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis : A prospective randomized controlled study. Der Orthopade. 2019 Mar:48(3):239-247. doi: 10.1007/s00132-018-03659-5. Epub
[PubMed PMID: 30623236]
Level 1 (high-level) evidence